Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

This Tech Stock Is 'Too Expensive,' Cramer Says: 'Wait For A Pullback'

Published 08/12/2023, 14:07
Updated 08/12/2023, 15:10
© Reuters.  This Tech Stock Is 'Too Expensive,' Cramer Says: 'Wait For A Pullback'
ANF
-
NUE
-
CAMT
-
NVAX
-
EYPT
-
AEO
-
ATKR
-
COIN
-

Benzinga - by Avi Kapoor, Benzinga Staff Writer.

On CNBC’s "Mad Money Lightning Round," Jim Cramer said Camtek Ltd. (NASDAQ: CAMT) is a "fabulous" company, but the stock is "too expensive." He recommended waiting for a pullback.

Cramer said he dislikes Novavax, Inc. (NASDAQ: NVAX) entirely. "I’ve done so for a very, very long time, even when it was much, much higher," he added.

When asked about Atkore Inc. (NYSE: ATKR), he said, "When I do anything involving steel, I immediately default to Nucor Corporation (NYSE: NUE). You have to do that, it’s the best in show."

Don’t forget to check out our premarket coverage here

The "Mad Money" host said he is worried about the fact that Coinbase Global, Inc. (NASDAQ: COIN) is "too expensive. Let it come in."

When asked about EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), he said, "The easy money has been made here. You got to find something else."

Cramer said American Eagle Outfitters, Inc. (NYSE: AEO) is good. "It did screw up in the past, though, I say Abercrombie & Fitch Co. (NYSE: ANF) is much better," he added.

Price Action:

  • Shares of Abercrombie & Fitch gained 1.1% to close at $77.94.
  • American Eagle rose 1.1% to $20.16 on Thursday.
  • EyePoint Pharmaceuticals gained 9.5% to $21.18.
  • Coinbase rose 1.2% to $136.19 during Thursday’s session.
  • Atkore shares gained 1.8%, while Nucor added 0.6%.
  • Novavax shares fell 0.9% to $5.53, while Camtek fell 0.7% to close at $62.15 on Thursday.

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.